Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-138293
Filing Date
2021-04-29
Accepted
2021-04-29 07:11:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d839557ddefa14a.htm DEFA14A 18010
2 GRAPHIC g839557g10k26.jpg GRAPHIC 259940
3 GRAPHIC g839557g20m14.jpg GRAPHIC 262813
  Complete submission text file 0001193125-21-138293.txt   739208
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35945 | Film No.: 21867046
SIC: 2834 Pharmaceutical Preparations